NMTC Stock Earnings: NeuroOne Medical Tech Misses EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

NMTC stock results show that NeuroOne Medical Tech missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

The post NMTC Stock Earnings: NeuroOne Medical Tech Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.